Effects of glucagon‐like peptide‐1 analogue treatment in genetic obesity: A case series

Obesity is highly prevalent and comes with serious health burden. In a minority, a genetic cause is present which often results in therapy‐resistant obesity. Liraglutide is a glucagon‐like peptide‐1 (GLP‐1) analogue, which has beneficial effects on satiety and weight in common obesity. We present th...

Descripción completa

Detalles Bibliográficos
Autores principales: Welling, Mila S., de Groot, Cornelis J., Kleinendorst, Lotte, van der Voorn, Bibian, Burgerhart, Jan Steven, van der Valk, Eline S., van Haelst, Mieke M., van den Akker, Erica L. T., van Rossum, Elisabeth F. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286843/
https://www.ncbi.nlm.nih.gov/pubmed/34291582
http://dx.doi.org/10.1111/cob.12481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286843/
https://www.ncbi.nlm.nih.gov/pubmed/34291582
http://dx.doi.org/10.1111/cob.12481

Ejemplares similares